The Genetic Association Information Network (GAIN) is a public-private partnership established to investigate the genetic basis of common diseases through a series of collaborative genome-wide association studies. GAIN has used new approaches for project selection, data deposition and distribution, collaborative analysis, publication and protection from premature intellectual property claims. These demonstrate a new commitment to shared scientific knowledge that should facilitate rapid advances in understanding the genetics of complex diseases.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
High-throughput sequencing in plant disease management: a comprehensive review of benefits, challenges, and future perspectives
Phytopathology Research Open Access 12 September 2023
-
A significant, functional and replicable risk KTN1 variant block for schizophrenia
Scientific Reports Open Access 08 March 2023
-
Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores
Translational Psychiatry Open Access 18 September 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Amundadottir, L.T. et al. A common variant associated with prostate cancer in European and African populations. Nat. Genet. 38, 652–658 (2006).
Gudmundsson, J. et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet. 39, 631–637 (2007).
Yeager, M. et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39, 645–649 (2007).
Sladek, R. et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881–885 (2007).
Saxena, R. et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331–1336 (2007).
Scott, L.J. et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341–1345 (2007).
McPherson, R. et al. A common allele on chromosome 9 associated with coronary heart disease. Science 316, 1488–1491 (2007).
Easton, D.F. et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087–1093 (2007).
Hunter, D.J. et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 39, 870–874 (2007).
The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678 (2007).
International HapMap Consortium. A haplotype map of the human genome. Nature 437, 1299–1320 (2005).
Wang, W.Y.S., Barratt, B.J., Clayton, D.G. & Todd, J.A. Genome-wide association studies: theoretical and practical concerns. Nat. Rev. Genet. 6, 109–118 (2005).
Duerr, R.H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461–1463 (2006).
Chanock, S.J. et al. NCI-NHGRI Working Group on Replication in Association Studies. Replicating genotype-phenotype associations. Nature 447, 655–660 (2007).
Schlesselman, J.J. Case-Control Studies: Design, Conduct, and Analysis 33–34 (Oxford University Press, New York, 1982).
McGuire, A.L. & Gibbs, R.A. Genetics. No longer de-identified. Science 312, 370–371 (2006).
Department of Health and Human Services. 45 CFR 46 Subpart A: Federal Policy for the Protection of Human Subjects (revised). Fed. Regist. 70, 36325–36328 (2005).
Department of Health and Human Services. 45 CFR 164.514: Other requirements relating to uses and disclosures of protected health information. Fed. Reg. 65, 82818–82819 and 67, 53270 (2000).
Todd, J.A., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39, 857–864 (2007).
Parkes, M., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 39, 830–832 (2007).
Kuntsi, J., Neale, B.M., Chen, W., Faraone, S.V. & Asherson, P. The IMAGE project: methodological issues for the molecular genetic analysis of ADHD. Behav. Brain Funct. 2, 27 (2006).
Mueller, P.W. et al. Genetics of Kidneys in Diabetes (GoKinD) Study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J. Am. Soc. Nephrol. 17, 1782–1790 (2006).
Suarez, B.K. et al. Genomewide linkage scan of 409 European-Ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am. J. Hum. Genet. 78, 315–333 (2006).
Dick, D.M. et al. Genomewide linkage analyses of bipolar disorder: A new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. Am. J. Hum. Genet. 73, 107–114 (2003).
Acknowledgements
The authors express their appreciation to P. de Bakker for providing estimates of genomic coverage for the GAIN genotyping platforms. The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278-01 (S. Gabriel, principal investigator) from the National Center for Research Resources.
The complete list of authors (the GAIN Collaborative Research Group) is as follows: Teri A Manolio1, Laura Lyman Rodriguez1, Lisa Brooks1, Gonçalo Abecasis2, the Collaborative Association Study of Psoriasis, Dennis Ballinger3, Mark Daly4, Peter Donnelly5, Stephen V Faraone6, the International Multi-Center ADHD Genetics Project, Kelly Frazer3,7, Stacey Gabriel4, Pablo Gejman8, the Molecular Genetics of Schizophrenia Collaboration, Alan Guttmacher1, Emily L Harris1, Thomas Insel9, John R Kelsoe10, the Bipolar Genome Study, Eric Lander4, Norma McCowin11, Matthew D Mailman12,13, Elizabeth Nabel14, James Ostell13, Elizabeth Pugh15, Stephen Sherry13, Patrick F Sullivan16, the Major Depression Stage 1 Genomewide Association in Population-Based Samples Study, John F Thompson17, James Warram18, the Genetics of Kidneys in Diabetes (GoKinD) Study, David Wholley11, Patrice M Milos19, Francis S Collins1
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
D.B. is an employee of Perlegen Sciences, Inc. K.F. was an employee of Perlegen Sciences, Inc. within the last year. M.D.M. is an employee of Eli Lilly and Co. P.M.M. was an employee of Pfizer, Inc. within the past year, and is currently an employee of Helicos BioSciences Corp. J.F.T. is an employee of Pfizer, Inc.
Supplementary information
Supplementary Text and Figures
Supplementary Table 1, Supplementary Note (PDF 27 kb)
Rights and permissions
About this article
Cite this article
The GAIN Collaborative Research Group. New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat Genet 39, 1045–1051 (2007). https://doi.org/10.1038/ng2127
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng2127
This article is cited by
-
High-throughput sequencing in plant disease management: a comprehensive review of benefits, challenges, and future perspectives
Phytopathology Research (2023)
-
A significant, functional and replicable risk KTN1 variant block for schizophrenia
Scientific Reports (2023)
-
CDH13 and LPHN3 Gene Polymorphisms in Attention-Deficit/Hyperactivity Disorder: Their Relation to Clinical Characteristics
Journal of Molecular Neuroscience (2021)
-
Detecting PCOS susceptibility loci from genome-wide association studies via iterative trend correlation based feature screening
BMC Bioinformatics (2020)
-
Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores
Translational Psychiatry (2020)